Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02521870 |
|---|---|
| Brief Title: | A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma |
| First Submitted : | July 30, 2015 |
| First Submitted that Met QC Criteria : | August 10, 2015 |
| First Posted : | August 13, 2015 (Estimate) |
| Results First Submitted : | April 30, 2021 |
| Results First Submitted that Met QC Criteria : | July 12, 2021 |
| Results First Posted : | August 3, 2021 |
| Last Update Submitted that Met QC Criteria : | July 12, 2021 |
| Last Update Posted : | August 3, 2021 |